Skip to main content

SOP for Technology Transfer

 SOP for Technology Transfer

Standard operating procedure for transfer the pharmaceutical product manufacturing technology from one site to another.

1.0 OBJECTIVE:

To lay down the procedure that the required information, data and technology about the product, processing and analysis is transferred and available at the site so that quality and integrity are maintained.

2.0 SCOPE:

This SOP shall be applicable to the new products which are transferred from R&D or all other product from one site to another site or from contract giver.

3.0 RESPONSIBILITY:

R&D Head / Head QA & QC / GM-Production / Unit Head / Contract Giver.

4.0 ACCOUNTABILITY:

Head- QA & QC

5.0 PROCEDURE:

5.1 Ensure the new product proposal is approved by QA.

5.2 Manufacturing license for a commercial production or test license for registration batches for the proposed product shall be obtained from local FDA.

5.3 Technology transfer documents shall be received from R&D or contract giver.

5.4 Analytical method transfer shall be carried out by using approved protocol given by R&D or contract giver.

5.4.1 Upon completion of analytical method transfer, data shall be compiled; report shall be prepared and sent to R&D or contract giver for review.

5.4.2 Method transfer shall be accepted if results are meeting the acceptance criteria.

5.4.3 The same method shall be used during the routine testing performed subsequently.

5.5 Technology transfer document shall include;

5.5.1 Analytical method for API (Active Pharmaceutical Ingredient(s)) inclusive of critical tests like assay, related substances and residual solvents.

5.5.2 In-process analytical methods.

5.5.3 Finished product analytical method inclusive of critical tests like assay, dissolution, related substances and dissolution profile.

5.5.4 Master formula record or process instructions.

5.6 Based on the technology transfer documents and analytical method transfer, the following documents shall be prepared and approved;

5.6.1 Batch manufacturing record

5.6.2 Validation protocol

5.6.3 Batch packaging record

5.6.4 Specification for API, excipients, in-process and finished product.

5.7 For site variation, the existing method/formula as used in the license shall be adopted. Separate technology transfer is not required in case of site transfer products as the same process of manufacturing is adopted on the basis of existing MFR provided by R&D (contract manufacturing department), any difficulty or deviation observed from the process, the specification shall be handled by coordinating with R&D.

5.8 For new products launched at any facility by R&D, analytical method transfer shall be routed through a product-specific protocol.

5.9 In case if any change in approved formula, prior approval from contract giver shall be taken.

5.10 The confirmation batches, registration batches shall be manufactured under the technical guidance of R&D or contract giver as per approved

validation protocol or batch manufacturing record.

5.11 Necessary training shall be provided to the concerned people.

5.12 In case of any deviation from the approved protocol or BMR, deviation control procedure shall be followed.

Related: Analytical Method Development

6.0 ABBREVIATIONS:

6.1 SOP: Standard Operating Procedure


6.2 QA: Quality Assurance

6.3 QC: Quality Control

6.4 R&D: Research and Development

6.5 FDA: Food and Drug Administration

6.6 API: Active Pharmaceutical Ingredient

6.7 MFR: Master Formula Record

6.8 BMR: Batch Manufacturing Record

Labels:

Comments

Post a Comment

If you have any doubts, please let me know

Popular posts from this blog

Checklist for Audit in Sterile Area

Checklist for Audit in Sterile Area Checklist to verify the sterile manufacturing area before the audit. 1. Is there any SOP giving details for activity/ movement in the sterile area. 2. Verify the suitability of system for sanitization of hands. 3. Is there the SOP on entry-exit; gowning and de-gowning into the critical area available? 4. Verify the availability of following records:  Air pressure differential  Particulate monitoring  Temperature  Humidity  Microbiological monitoring by settle plate 5. Are these records available and maintained as per SOPs? 6. Check the above mentioned individual records. Are the entries within specifications mentioned in SOP/ MTPs. 7. Is the controlled copy of MTP pertaining to monitoring by settle plate available to plant person? 8. Are the location for settle plates identified and the chart/ layout available with plant? 9. Are the following areas monitored for parameters mentioned in step 4:  Air-lock to the critical ar...
Post a Comment
Read more

Aseptic Filling Process (Media Fill) Validation Protocol in Sterile Pharmaceuticals

Aseptic Filling Process (Media Fill) Validation Protocol in Sterile Pharmaceuticals Validation of sterile manufacturing process by media fill validation test as per PICS guidelines for aseptic validation or aseptic process simulation. 1.0 OBJECTIVE 1.1 To define procedures for validating and maintaining the validation of all aseptic filling processes and qualification of the quality of the product by system/facility/equipment. 2.0 SCOPE 2.1 This procedure applies to all aseptically filled sterile products intended for human use. 3.0 RESPONSIBILITY 3.1 The Validation personnel coordinate the aseptic filling validation program and write the sterile media aseptic filling processes reports. 3.2 Manufacturing personnel the sterile media aseptic filling processes and performs the sterile media fills. 3.3 QA personnel perform the sampling and assist with the IPQA monitoring required for each sterile media fill. 3.4 QC personnel to perform the testing and assist with the monitoring required fo...
Post a Comment
Read more

Blow Fill Seal (BFS) and Form Fill Seal (FFS) Technology in Sterile Manufacturing

Blow Fill Seal (BFS) and Form Fill Seal (FFS) Technology in Sterile Manufacturing Know about sterile pharmaceutical production using Blow Fill Seal (BFS) and Form Fill Seal (FFS) technology. Both of these techniques are used to manufacture  sterile pharmaceutical products   as parenteral (LVP & SVP), infusions, ophthalmic and inhalation products. These are automated techniques to prepare sterile products. The basic concept of the  FFS   and BFS is to reduce the  contamination   by forming the container, filling and sealing in a closed sterile chamber of the machine. There is no personnel intervention to reduce the chances of the contamination during the manufacturing of sterile products. It gives more production at very low operational cost with the high assurance of  sterility . Blow fill seal technology is widely used and accepted by the various pharmaceutical regulatory authorities as US-FDA and MHRA. The system is being used for over 30 years a...
Post a Comment
Read more